Current Gene Therapy
Volume 22, 5 Issues, 2022
ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)
This journal supports open access
ISSN: 1566-5232 (Print)
ISSN: 1875-5631 (Online)
This journal supports open access
Contents
Current Gene Therapy , Volume 15 - Number 2
Editorial
Editorial (Thematic Issue: Gene Therapy for Gastrointestinal and Liver Cancers: Past Experience, Current Status and Future Perspectives)
, 15(2): 93 - 96George Wilson, Lionel Hebbard, Wei Duan, Jacob George and Liang Qiao
DOI: 10.2174/156652321502150309094913
Targeting Angiogenic Genes as a Therapeutic Approach for Hepatocellular Carcinoma
, 15(2): 97 - 108Chi Hang Wong, Cesar S.C. Wong and Stephen L. Chan
DOI: 10.2174/1566523214666141224094648
Aptamer-Mediated Cancer Gene Therapy
, 15(2): 109 - 119Dongxi Xiang, Sarah Shigdar, Greg Qiao, Shu-Feng Zhou, Yong Li, Ming Q. Wei, Liang Qiao, Hadi Al. Shamaileh, Yimin Zhu, Conglong Zheng, Chunwen Pu and Wei Duan
DOI: 10.2174/1566523214666141224095105
Current Status of Gene Therapy for Hepatocellular Carcinoma, with a Focus on Gene Delivery Approaches
, 15(2): 120 - 141Xiaoyu Wang, Zongguang Tai, Wei Zhang and Shen Gao
DOI: 10.2174/1566523214666141224095411
miR-122 is a Unique Molecule with Great Potential in Diagnosis, Prognosis of Liver Disease, and Therapy Both as miRNA Mimic and Antimir
, 15(2): 142 - 150Sharda Thakral and Kalpana Ghoshal
DOI: 10.2174/1566523214666141224095610
Combined Therapy for Gastrointestinal Carcinomas: Exploiting Synergies Between Gene Therapy and Classical Chemo-Radiotherapy
, 15(2): 151 - 160Mariana Malvicini, Jorge B. Aquino and Guillermo Mazzolini
DOI: 10.2174/1566523214666141224095757
Targeting Cancer Stem Cells as a Therapeutic Approach in Liver Cancer
, 15(2): 161 - 170Gang Zhou, George Wilson, Jacob George and Liang Qiao
DOI: 10.2174/1566523214666141224095938
Modulation of Notch Signaling as a Therapeutic Approach for Liver Cancer
, 15(2): 171 - 181Guang Wu, George Wilson, Jacob George and Liang Qiao
DOI: 10.2174/1566523214666141224100319
Exosomes: A Role for Naturally Occurring Nanovesicles in Cancer Growth, Diagnosis and Treatment
, 15(2): 182 - 192Akhil Srivastava, Justyna Filant, Katherine M. Moxley, Anil Sood, Scott McMeekin and Rajagopal Ramesh
DOI: 10.2174/1566523214666141224100612
Apoptosis-Induction is A Novel Therapeutic Strategy for Gastrointestinal and Liver Cancers
, 15(2): 193 - 200Fei Wang, Haizhong Wang, Xiaotian Sun and Min Li
DOI: 10.2174/1566523214666141224100801
SiRNA Nanotherapeutics _The Panacea of Diseases?
, 15(2): 201 - 214Khan Farheen Badrealam, Swaleha Zubair and Mohammad Owais
DOI: 10.2174/1566523215666150122130047
Editor-in-Chief
Liang Cheng
College of Bioinformatics, Science and Technology
Harbin Medical University
Harbin, Heilongjiang
(China)
Biography
College of Bioinformatics, Science and Technology
Harbin Medical University
Harbin, Heilongjiang
Biography
Biography of Liang Cheng
Dr. Cheng obtained a doctorate (Ph.D.) in Bioinformatics from Harbin Institute of Technology, Harbin, Heilongjiang, China. Currently Dr. Cheng is a Professor and PI of Biological Software Engineering in Harbin Medical University. He has published more than 70 scientific publications since 2013. Dr. Cheng develops novel algorithms and tools for gene therapy of Type 2 Diabetes Mellitus and complex diseases.
COPE Compliant
About the Journal
⇨ Journal Home⇨ Editorial Policies⇨ Fabricating and Stating False Information⇨ Research Misconduct⇨ Post Publication Discussions and Corrections⇨ Allegations from Whistleblowers⇨ Editorial Board⇨ Board Recruitment Workflow⇨ Short Guide⇨ Join Editorial Board⇨ Indexing Information⇨ Announcements⇨ Endorsements⇨ Authors' Comments⇨ Special Offers
For Authors
For Librarians & Readers
Quick Links
Webmaster Contact: info@benthamscience.net